Wells Fargo’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776 | Sell |
2,494
-49,014
| -95% | -$15.3K | ﹤0.01% | 5872 |
|
|
2025
Q1 | $25.2K | Buy |
51,508
+2,051
| +4% | +$1K | ﹤0.01% | 5176 |
|
|
2024
Q4 | $42.3K | Buy |
49,457
+13,721
| +38% | +$11.7K | ﹤0.01% | 5051 |
|
|
2024
Q3 | $304K | Buy |
35,736
+440
| +1% | +$3.74K | ﹤0.01% | 3926 |
|
|
2024
Q2 | $165K | Buy |
35,296
+34,861
| +8,014% | +$163K | ﹤0.01% | 4284 |
|
|
2024
Q1 | $2.96K | Buy |
435
+7
| +2% | +$48 | ﹤0.01% | 5577 |
|
|
2023
Q4 | $1.43K | Sell |
428
-76
| -15% | -$255 | ﹤0.01% | 5706 |
|
|
2023
Q3 | $1.26K | Buy |
504
+162
| +47% | +$403 | ﹤0.01% | 5788 |
|
|
2023
Q2 | $438 | Buy |
342
+69
| +25% | +$88 | ﹤0.01% | 6208 |
|
|
2023
Q1 | $221 | Buy |
273
+5
| +2% | +$4 | ﹤0.01% | 6425 |
|
|
2022
Q4 | $204 | Buy |
268
+7
| +3% | +$5 | ﹤0.01% | 6290 |
|
|
2022
Q3 | $0 | Buy |
261
+142
| +119% | – | ﹤0.01% | 6287 |
|
|
2022
Q2 | $0 | Sell |
119
-1,346
| -92% | – | ﹤0.01% | 6458 |
|
|
2022
Q1 | $3K | Sell |
1,465
-6,255
| -81% | -$12.8K | ﹤0.01% | 6210 |
|
|
2021
Q4 | $69K | Buy |
7,720
+7,718
| +385,900% | +$69K | ﹤0.01% | 5382 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 6596 |
|
|
2021
Q2 | $0 | Sell |
2
-2,409
| -100% | – | ﹤0.01% | 6517 |
|
|
2021
Q1 | $45K | Sell |
2,411
-7,374
| -75% | -$138K | ﹤0.01% | 5503 |
|
|
2020
Q4 | $215K | Buy |
9,785
+337
| +4% | +$7.41K | ﹤0.01% | 4915 |
|
|
2020
Q3 | $196K | Sell |
9,448
-2,486
| -21% | -$51.6K | ﹤0.01% | 4806 |
|
|
2020
Q2 | $432K | Buy |
11,934
+6,657
| +126% | +$241K | ﹤0.01% | 4311 |
|
|
2020
Q1 | $172K | Buy |
5,277
+1,553
| +42% | +$50.6K | ﹤0.01% | 4595 |
|
|
2019
Q4 | $102K | Buy |
3,724
+3,562
| +2,199% | +$97.6K | ﹤0.01% | 5080 |
|
|
2019
Q3 | $2K | Buy |
+162
| New | +$2K | ﹤0.01% | 5727 |
|